<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="vaccines.7 In case of an epidemic, neuraminidase inhibitors such as" exact="oseltamivir" post="or zanamivir can be used to reduce the illness"/>
 <result pre="case of an epidemic, neuraminidase inhibitors such as oseltamivir or" exact="zanamivir" post="can be used to reduce the illness symptoms and"/>
 <result pre="spacers for enhanced multivalency effects.41−43 Compound 3 is a polymeric" exact="dextran" post="scaffold44 for comparison with the &quot;small�? molecule scaffolds 1"/>
 <result pre="of 8. cNot determined. din the presence of 10 μM" exact="oseltamivir" post="carboxylate. First to note is that the inhibition with"/>
 <result pre="were run in the presence of 10 μM neuraminidase inhibitor" exact="oseltamivir" post="carboxylate (OC) to inhibit the neuraminidase that could potentially"/>
 <result pre="μM) of 14, 15, and 12 in the presence of" exact="oseltamivir" post="carboxylate, with the same experiments without the NA inhibitor."/>
 <result pre="first, similar degrees of inhibition and, second, no effect of" exact="oseltamivir" post="carboxylate. Besides the BLI assay, also a hemagglutination inhibition"/>
 <result pre="could be observed between HA inhibitor 15 and NA inhibitor" exact="oseltamivir" post="carboxylate. Low nanomolar concentrations of each showed little effect,"/>
 <result pre="it was remarkable that no effect of the NA inhibitor" exact="oseltamivir" post="carboxylate was observed. Furthermore, in the infection inhibition assay"/>
</results>
